JoonHui Lee

Researcher/Developer

HippoT&C

Suwon, South Korea

12 profile visits

HippoT&C develops digital therapeutics mainly for mental disorder(ADHD, ODD, etc.). Our software are based on various platform, such as VR, AR, and tablet.

My organisation

HippoT&C

HippoT&C

Startup

Suwon, South Korea

Founded in 2020, HippoT&C is dedicated to developing digital therapeutics for the diagnosis and treatment of psychological disorders. Our motto, "Elevate positive, mitigate negative" reflects our commitment to analyzing individual patient characteristics and providing tailored treatments. With a focus on leveraging cutting-edge IT technologies, we aim to revolutionize the medical service paradigm for the benefit of both patients and doctors. We participated in CES 2022, 2023 and achieved Innovation Award in CES 2022 for AttnKare-D. We are currently focusing on two types of mental disorder : ADHD(Attention-Deficit Hyperactivity Disorder) and MDD(Major Depression Disorder). ADHD related softwares are AttnKare-D, VR based digital diagnosis software for ADHD children, and AttnKare-T, tablet based digital therapeutics for young ADHD patients. MDD related softwares are Blukare-T, mobile digital therapeutics with AR functions for MDD patients. Our company is also working on developing BlueKare-D, digital diagnosis software for MDD using biomarkers. Our company's goals is to combine multiple digital technologies to provide best solutions for mental disorder patients.
Read more

About me

I am currently working at HippoT&C as a VR software developer since 2021.

I double-majored in Psychology and Computer science, and became interested in digital therapeutics, which I believe is the true essence of the combination of those two studies.

Here in HippoT&C, I develop VR software using Unity, which is widely used platform for VR, AR and tablet.

Working with many medical professionals, I was able to gain more knowledge about various mental disorder, such as ADHD and ADD. By applying this knowledge to Attnkare-D, my team was able to develop software rich in psychological aspects.
As working in the field of digital therapeutics, I found it very difficult to adjust the thin limit between "game" and "medicine". My team not only had to adapt to be appropriate to the young children, but also to be entertainment enough to play. We had ups and downs, but eventually Attnkare-D is facing confirmatory clinical trials in Korea and preparing FDA clearance in USA.

I believe digital therapeutics can help those who suffer from mental disorder by overcoming difficulties of the conventional medical aids.

My organisation

HippoT&C

Skills

  • Unity
  • vr

Interests

  • vr
  • DigitalTherapeutics

Marketplace (2)

  • Service

    AttnKare

    AttnKare is the digital therapeutics for ADHD children. AttnKare is consisted of two solutions : AttnKare-D and AttnKare-T.

    • Others
    • Consulting
    • Distribution
    • Digital Health
    • Research and Development
    Author

    JoonHui Lee

    Researcher/Developer at HippoT&C

    Suwon, South Korea